Differential Characteristics of Patients for Hospitalized Severe COVID-19 Infected by the Omicron Variants and Wild Type of SARS-CoV-2 in China
Yuan-Yuan Wei,Rui-Rui Wang,Da-Wei Zhang,Su-Hong Chen,Yuan-Yuan Tan,Wen-Ting Zhang,Ming-Feng Han,Guang-He Fei
DOI: https://doi.org/10.2147/jir.s420721
IF: 4.5
2023-07-22
Journal of Inflammation Research
Abstract:Yuan-Yuan Wei, 1, 2, &ast Rui-Rui Wang, 3, &ast Da-Wei Zhang, 1, 2, &ast Su-Hong Chen, 2, 4 Yuan-Yuan Tan, 2, 5 Wen-Ting Zhang, 1, 2 Ming-Feng Han, 3 Guang-He Fei 1, 2 1 Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China; 2 Key Laboratory of Respiratory Diseases Research and Medical Transformation of Anhui Province, Hefei, Anhui, 230022, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Fuyang, Anhui, 236015, People's Republic of China; 4 Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China; 5 Department of Emergency Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guang-He Fei, Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China, Tel +8655162922013, Fax +8655163635578, Email Ming-Feng Han, Department of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Fuyang, Anhui, 236015, People's Republic of China, Email Background: As multiple mutations of SARS-Cov-2 exist, there are now many viral variants with regional differences in distribution. The clinical characteristics of patients hospitalized with the virus also vary significantly, with those of the Omicron variants being strikingly different from those of the earliest wild-type variant. However, comprehensive data on this subject is lacking. It is therefore crucial to explore these differences to develop better clinical strategies for the management of COVID-19 . Methods: A total of 554 confirmed COVID-19 cases in China were clinically classified as mild, moderate, severe, and critical according to their diagnoses and treatment plans. We compared the demographics and clinical characteristics of patients infected with the Omicron vs wild-type strains, between severe and non-severe cases. Bacterial co-infections with SARS-CoV-2 and correlation between inflammatory factors and T cells were analyzed. Results: Compared to the wild-type cases, the severe Omicron cases were older (median age 48.36 vs 73.24), and had more upper-respiratory symptoms and comorbidities. Decreased leukocyte counts were less pronounced, although more instances of significantly decreased CD4+ and CD8+ T-cell counts, elevated infection-related biomarkers (eg procalcitonin and C-reactive protein), and abnormal coagulation factors (including increased D-dimer and fibrinogen levels) were detected in the severe Omicron cases. The mean length of hospital stay was significantly shorter in the severe Omicron cases. CD4+ and CD8+ T cell numbers were negatively correlated with neutrophil-to-lymphocyte ratios, as well as serum interleukin-6, procalcitonin, and C-reactive protein levels. Conclusion: There were significant clinical differences between patients hospitalized with severe cases of Omicron- variant COVID-19 vs wild-type. The Omicron cases tended to be older and had more upper respiratory tract symptoms, comorbidities and bacterial co-infections. Elevated levels of inflammatory cytokines with T-cell depletion correlated with poor disease progression and prognosis. We hope these data provide a theoretical basis for future integrated prevention and control plans for COVID-19 . Keywords: COVID-19 , Omicron variants, wild-type SARS-CoV-2 , clinical characteristics, T cell depletion Coronavirus disease 2019 (COVID-19) is an acute fulminant infectious respiratory disease that spread rapidly worldwide. 1–3 Human-to-human transmission is the main route of spread for most COVID-19 infections, and its many mutations have raised concerns regarding its pathogenicity and ability to cause severe illness. 4 There are now several variants of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus, including Alpha, Beta, Gamma, Delta, and Omicron variants, which vary in both temporal and regional distribution. Compared to the wild-type virus, the Omicron variants have several mutations in their spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins and were first identified in South Africa and Botswana on Nove -Abstract Truncated-
immunology